• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches  

Beta-carotene with vitamins E and C offers synergistic cell protection against NOx

Print Email
Published on Thursday, 30 August 2018

Abstract

The peroxynitrite anion and the nitrogen dioxide (radical) are important toxic species which can arise in vivo from nitric oxide.

Both in vivo and in vitro cell protection is demonstrated for beta-carotene in the presence of vitamin E and vitamin C.

A synergistic protection is observed compared to the individual anti-oxidants and this is explained in terms of an electron transfer reaction in which the beta-carotene radical is repaired by vitamin C.

 



Download the complete article

About this publication.

See also:

- Beta-Carotene or β-carotene in Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;

- The Di Bella Method (A Fixed Part - All-Trans Retinoic Acid, Analogues and/or Derivatives - Approximately 60mg per day orally: 40mg per day Beta-Carotene/β-Carotene, 10mg per day ATRA and 10mg per day Axerophthol palmitate);

- All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives) - In vitro, review and in vivo publications;

- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;

- The Di Bella Method (A Fixed Part - Alpha tocopheryl acetate/Vitamin E, approximately 20 grams per day orally);

- The Di Bella Method (A Fixed Part - Vitamin C/Ascorbic Acid, 2–4 grams per day orally).

Search

Follow us...

Latest

  • Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage
  • Melatonin as antioxidant, geroprotector and anticarcinogen
  • The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor
  • Does the use of melatonin overcome drug resistance in cancer chemotherapy?
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
  • Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
  • Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms
  • Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management
  • Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality
  • Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture
  • Melatonin for the Management of Cancer-Related Fatigue in Breast Cancer: An Integrative Review
  • Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer
  • Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells
  • Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells
  • Melatonin: an ancient molecule that makes oxygen metabolically tolerable
  • Molecular and cellular mechanisms of melatonin in breast cancer
  • Melatonin as an adjuvant treatment modality with doxorubicin

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Bibliography
  • How effective is chemo therapy?
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer